Twitter

About us

Kriba

Kriba is a medical device startup that enables non-invasive screening, detection and monitoring of serous body fluids infections. Our non-invasive white blood cell counter in serous liquids is unique and answers to the need to quickly, easily and cost-effectively detect these infections.
AI powered early detection solutions for agile and swift screening of infections of serous fluids.
Serous fluid infections can kill in a few hours or days and leave permanent sequelae if not detected promptly. Suspecting the presence of these infections in the early stages is very complicated because the signs and symptoms are very non-specific. Kriba arises from an unmet medical need of high global impact: the early non-invasive detection of potentially life-threatening and disabling infections in serous fluids. The company was launched in 2015 with the desire to revolutionize the field of medical devices for non-invasive monitoring and screening of infant meningitis.
Founded by Javier Jimenez, PhD, MBA and CEO of the company after his participation in the M+Visión program, an initiative of the Madri+d Foundation and the Massachusetts Institute of Technology (MIT) to leverage the biomedical industry in the Regional Government of Madrid. Madrid-MIT M+Visión researchers are selected from all over the world to form multinational and multicultural teams to generate technology-based ideas that solve unmet medical needs.
AI powered early detection solutions for agile and swift screening of infections of serous fluids.
Encouraged by the demand of our key opinion leaders, the device is being tested to show clinical feasibility in different applications for infection screening in serous body fluids. The company is also developing predictive models exploiting clinical, blood and the non-invasive white blood cells count to further support diagnostic and treatment decisions. Today a growing team, Kriba is attracting talent as our activities keep on flourishing and has established itself at the heart of the Barcelona Science Park, where research and innovation thrives. We are regularly recognized and given support by distinguished industry, clinical peers, and institutions.
ACCELERATING SCREENING OF INFECTIONS
ACCELERATING SCREENING OF INFECTIONS
ACCELERATING SCREENING OF INFECTIONS
ACCELERATING SCREENING OF INFECTIONS

Team

Network

At Newborn Solutions we generate impact, innovation and patient-oriented development in healthcare through our partnerships with:

Funding

We are proudly funded by:

Logo Comunidad de Madrid
Startup & SME (RIS3)
Logo AECID
In collaboration with ISGlobal
Logo Co-funded EU

H2020 SME Instrument Phase 1 – Grant Agreement 81738

Logo ACCIÓ Generalitat de Catalunya
Startup Capital –
Cupons a la indústria 4.0
Logo CDTI NEOTEC
NEOTEC grant
Logo EIT Health
Headstart grant medtech category
Logo EIT Health
Headstart grant medtech category
Logo Bill Melinda Gates Foundation
in collaboration with ISGlobal
Chips JU – Listen2Future – Grant Agreement 101096884
Logo Co-funded EU
EIC Accelerator Grant & Equity Funding – Grant Agreement 190155553

Recognitions